I would not want to be out of Genta going into this weekend.
Genta Market Cap last Friday when it was penny was $32M. $600 million market cap at this phase for Genta is not unreasonable and with good results from clinical trial completeion in the fall could be $2 Billion pre-FDA approval like Dendreon.
So based on a market cap of $320 million GENTA could trade to $0.10 and could head to $0.20 easily for $600+ market cap.
My guess if the ASCO meeting this weekend results in news for Genta, we could see $0.05 next week.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.